Edition:
United States

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

29.00INR
6:29am EDT
Change (% chg)

Rs0.40 (+1.40%)
Prev Close
Rs28.60
Open
Rs29.00
Day's High
Rs29.50
Day's Low
Rs28.25
Volume
2,131,195
Avg. Vol
2,372,536
52-wk High
Rs52.30
52-wk Low
Rs25.30

Latest Key Developments (Source: Significant Developments)

India's Marksans Pharma Dec-Qtr Consol Profit Rises
Monday, 12 Feb 2018 02:07am EST 

Feb 12 (Reuters) - Marksans Pharma Ltd ::DEC QUARTER CONSOL PROFIT 174.6 MILLION RUPEES VERSUS PROFIT 115.2 MILLION RUPEES YEAR AGO.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 2.18 BILLION RUPEES VERSUS 2.15 BILLION RUPEES YEAR AGO.  Full Article

India's Marksans Pharma Sept-qtr consol profit rises
Monday, 13 Nov 2017 02:24am EST 

Nov 13 (Reuters) - Marksans Pharma Ltd ::Sept quarter consol profit 104.1 million rupees versus profit of 7.5 million rupees year ago.Sept quarter consol revenue from operations 2.74 billion rupees versus 1.80 billion rupees year ago.  Full Article

India's Marksans Pharma June-qtr profit falls
Friday, 11 Aug 2017 04:56am EDT 

Aug 11 (Reuters) - Marksans Pharma Ltd :June quarter profit 11.6 million rupees versus profit 40.5 million rupees year ago.June quarter total income 524.3 million rupees versus 417.9 million rupees year ago.  Full Article

India's Marksans Pharma March-qtr profit tanks
Monday, 29 May 2017 03:42am EDT 

May 29 (Reuters) - Marksans Pharma Ltd :March quarter profit 5.7 million rupees versus profit 50.8 million rupees year ago.March quarter total income 541 million rupees versus 758.2 million rupees year ago.Recommended dividend of 0.05 rupees per share.  Full Article

Marksans Pharma's Goa plant gets approved by UK MHRA
Wednesday, 10 May 2017 03:25am EDT 

May 10 (Reuters) - Marksans Pharma Ltd :Says company's Goa plant has been approved by UK MHRA..  Full Article

Marksans Pharma gets GMP compliance certificate from Australian health dept.
Wednesday, 26 Apr 2017 05:26am EDT 

April 26 (Reuters) - Marksans Pharma Ltd :Marksans Pharma -received "certificate of GMP compliance of a manufacturer" from Australian government, Department of Health, Therapeutic Goods Administration.  Full Article

Marksans Pharma says USFDA gives four 483 observations to manufacturing facilties in Goa
Monday, 10 Apr 2017 03:11am EDT 

Marksans Pharma Ltd : Marksans Pharma Ltd says USFDA inspects manufacturing facilty at L-82, L-83 in Goa . Marksans Pharma Ltd says 4 observations given under form 483 . Marksans Pharma Ltd says co started addressing observations .Marksans Pharma Ltd says USFDA granted final approval for ANDA for dutasteride soft gealtine capsule.  Full Article

Marksans Pharma says UK MHRA completed inspection at co's Goa plant without any critical observations
Monday, 20 Feb 2017 02:02am EST 

Marksans Pharma Ltd : Says company's plant located at Goa has had an inspection by UK MHRA from February 14, 2017 to February 17, 2017 .Says inspection has been completed without any critical observations.  Full Article

Marksans Pharma Dec qtr consol profit falls
Monday, 6 Feb 2017 05:21am EST 

Marksans Pharma Ltd : Marksans Pharma Ltd - dec quarter consol net profit 113 million rupees versus profit 179.3 million rupees year ago .Marksans Pharma Ltd - dec quarter consol net sales 2.15 billion rupees versus 2.17 billion rupees year ago.  Full Article

Marksans Pharma gets USFDA nod for drug to treat allergies
Monday, 26 Sep 2016 01:13am EDT 

Marksans Pharma Ltd :Marksans Pharma Limited announces USFDA approval for loratadine liquid filled capsules 10 mg.  Full Article

BRIEF-India's Marksans Pharma Dec-Qtr Consol Profit Rises

* DEC QUARTER CONSOL PROFIT 174.6 MILLION RUPEES VERSUS PROFIT 115.2 MILLION RUPEES YEAR AGO